Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the ...
The immune system provides constant surveillance for the body, aiming to spot and eliminate disease-causing microbes or ...
An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases. GigaPath, an artificial intelligence (AI) model, may predict cancer mutations including ...
The topographical features of DNA in the body may dictate where and when cancer-causing mutations appear in its code. When you purchase through links on our site, we may earn an affiliate commission.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback